Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Wim van Boxtel; Eline Boon; Willem L J Weijs; Frank J A van den Hoogen; Uta E Flucke; Carla M L van Herpen

doi:10.1016/j.oraloncology.2017.06.023

Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma

Oral Oncol. 2017 Sep:72:198-200. doi: 10.1016/j.oraloncology.2017.06.023. Epub 2017 Jun 30.

Authors

Wim van Boxtel¹, Eline Boon², Willem L J Weijs³, Frank J A van den Hoogen⁴, Uta E Flucke⁵, Carla M L van Herpen⁶

Affiliations

¹ Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: wim.vanboxtel@radboudumc.nl.
² Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: eline.boon@radboudumc.nl.
³ Department of Oral and Maxillofacial Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: willem.weijs@radboudumc.nl.
⁴ Department of Otorhinolaryngology/Head and Neck Surgery, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: frank-KNO.vandenhoogen@radboudumc.nl.
⁵ Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: Uta.flucke@radboudumc.nl.
⁶ Department of Medical Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525 AG Nijmegen, The Netherlands. Electronic address: Carla.vanHerpen@radboudumc.nl.

PMID: 28673692
DOI: 10.1016/j.oraloncology.2017.06.023

No abstract available

Keywords: Ado-trastuzumab emtansine; Docetaxel; Head and Neck Neoplasms; Neoplasm metastasis; Pertuzumab; Receptor, ErbB-2; Salivary duct carcinoma; Salivary gland neoplasms; Trastuzumab.

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Docetaxel
Maytansine*
Receptor, ErbB-2
Salivary Ducts
Taxoids
Trastuzumab*

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Taxoids
Maytansine
Docetaxel
Receptor, ErbB-2
pertuzumab
Trastuzumab